FDA accepts for review Aldeyra Therapeutics’ resubmitted New Drug Application for reproxalap

Published on July 17, 2025
A Prescription Drug User Fee Act (PDUFA) target action date of December 16, 2025, was assigned by the FDA.
Continue reading on website
Other news

AOA advocacy efforts return more than $7.5 million to members

July 17, 2025
How the AOA and its volunteers are supporting their colleagues fighting unreasonable requests, downcoding, and claim denials.

AOA 2025: Innovation and education take forefront at Optometry's Meeting

July 17, 2025
ODs reflect on their time in Minneapolis, Minnesota, citing continuing education, tech updates, and networking opportunities as valued takeaways from the meeting.